3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Small Cell Lung Carcinoma
4
Ovarian Neoplasms
3
Stomach Neoplasms
2
Solid Tumor
2
Gastric Adenocarcinoma
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Two Different Treatment Methods
1
Squamous Cell Carcinoma of Head and Neck
1
Osteosarcoma
1
Mucosal Melanoma
1
Melanoma
1
Immunotherapy Gastrict Cancer
1
Immunotherapy
1
HER-2 Negatived Gastric Cancer
1
Carcinoma, Ovarian Epithelial
1
Advanced Triple Negative Breast Cancer
1
Advanced Metastatic Gastric Cancer
1
Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction
1
Advanced Gastric Cancer
1
Advanced Gastric Adenocarcinoma
1
Advanced Esophagus Cancer
1
Adenocarcinoma of Lung
1
Interventions
sintilimab
1
apatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Advanced Metastatic Gastric Cancer
×
apatinib
×
Clear all
NCT04089657
2019-09-13
ASGARD
Fujian Cancer Hospital
Phase 2
Unknown
40 enrolled